Co-mutation of p53, K-ras genes and accumulation of p53 protein and its correlation to clinicopathological features in rectal cancer

World Journal of Gastroenterology

Volumn 10, Issue 24, 2004, Pages 3688-3690

  Pan, Zhi Zhong ^a   Wan, De Sen ^a   Chen, Gong ^a   Li, Li Ren ^a   Lu, Zhen Hai ^a   Huang, Bi Jun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; PROTEIN P53;

ACCURACY; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER SIZE; CANCER STAGING; CARCINOGENESIS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE MUTATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MUTATION RATE; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PREDICTION; PROGNOSIS; RECTUM CANCER; SINGLE STRAND CONFORMATION POLYMORPHISM; SURVIVAL; TUMOR SUPPRESSOR GENE;

EID: 10244232910     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i24.3688     Document Type: Article

References (16)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767
2. Jin W, Gao MQ, Lin ZW, Yang DX. Multiple biomarkers of colorectal tumor in a differe diagnosis model: A quantitative study. World J Gastroenterol 2004; 10: 439-442
3. Klump B, Nehls O, Okech T, Hsieh CJ, Gaco V, Gittinger FS, Sarbia M, Borchard F, Greschniok A, Gruenagel HH, Porschen R, Gregor M. Molecular lesions in colorectal cancer: impact on prognosis? Original data and review of the literature. Int J Colorectal Dis 2004; 19 23-42
4. Galizia G, Lieto E, Ferraraccio F, Orditura M, De Vita F, Castellano P, Imperatore V, Romano C, Ciardiello F, Agostini B, Pignatelli C. Determination of molecular marker expression can predict clinical outcome in colon carcinomas. Clin Cancer Res 2004; 10 3490-3499
5. Soussi T. The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann N Y Acad Sci 2000; 910 121-137
6. Velculescu VE, El-Deiry WS. Biological and clinical importance of the p53 tumor suppressor gene. Clin Chem 1996; 42 (6 Pt 1): 858-868
7. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-4878
8. Fearon ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumors. Science 1987; 238: 193-197
9. Scott N, Quirke P. Molecular biology of colorectal neoplasia. Gut 1993; 34: 289-292
10. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51(23 Pt 1): 6304-6411
11. Hall PA, McKee PH, Menage HD, Dover R, Lane DP. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 1993; 8: 203-207
12. Wang Y, Liu S, Hao D. Mutations of APC gene MCR region in sporadic colorectal adenomas and carcinomas. Zhonghua Zhongliu Zazhi 1998; 20: 284-286
13. Qian H, Yu BM, Zhou XG, Wang RN, Huang W, Chen SJ, Chen Z. The significance of p53 gene mutations and expressions in human colorectal tumors. Zhonghua Zhongliu Zazhi 1995; 17: 332
14. Cunningham J, Lust JA, Schaid DJ, Bren GD, Carpenter HA, Rizza E, Kovach JS, Thibodeau SN. Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res 1992; 52: 1974-1980
15. Kawasaki Y, Monden T, Morimoto H, Murotani M, Miyoshi Y, Kobayashi T, Shimano T, Mori T. Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenoma. Am J Clin Pathol 1992; 97: 244-249
16. Bell SM, Scott N, Cross D, Sagar P, Lewis FA, Blair GE, Taylor GR, Dixon MF, Quirke P. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology 1993; 104: 57-64